Naohiro Sekiguchi

1.1k total citations
61 papers, 570 citations indexed

About

Naohiro Sekiguchi is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology. According to data from OpenAlex, Naohiro Sekiguchi has authored 61 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pathology and Forensic Medicine, 34 papers in Genetics and 28 papers in Hematology. Recurrent topics in Naohiro Sekiguchi's work include Lymphoma Diagnosis and Treatment (34 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Naohiro Sekiguchi is often cited by papers focused on Lymphoma Diagnosis and Treatment (34 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Naohiro Sekiguchi collaborates with scholars based in Japan, United States and United Kingdom. Naohiro Sekiguchi's co-authors include Yukio Kobayashi, Kensei Tobinai, Yoshihiro Matsuno, Kazuki Tanimoto, Takashi Watanabe, Akihiro Kaneko, Akiko Miyagi Maeshima, Yoshikazu Kagami, Shigenobu Suzuki and Takashi Watanabe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Naohiro Sekiguchi

56 papers receiving 556 citations

Peers

Countries citing papers authored by Naohiro Sekiguchi

Since Specialization

Citations

This map shows the geographic impact of Naohiro Sekiguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naohiro Sekiguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naohiro Sekiguchi more than expected).

Fields of papers citing papers by Naohiro Sekiguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naohiro Sekiguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naohiro Sekiguchi. The network helps show where Naohiro Sekiguchi may publish in the future.

Co-authorship network of co-authors of Naohiro Sekiguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Naohiro Sekiguchi. A scholar is included among the top collaborators of Naohiro Sekiguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naohiro Sekiguchi. Naohiro Sekiguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Report of Consensus Panel 2 from the 12th International Workshop on the management of Bing-Neel syndrome in patients with Waldenstrom’s Macroglobulinemia 2025 ·Seminars in Hematology ·Shayna Sarosiek, (unknown), Andrew R. Branagan, Simone Ferrero, Jahanzaib Khwaja, Eva Kimby, Damien Roos‐Weil, Naohiro Sekiguchi, Marek Trněný, Shuhua Yi, Christopher J. Patterson, Christian Buske, Jeffrey Matous, Steven P. Treon, Monique C. Minnema	0
2	Extramedullary hematopoietic pleural effusion in Waldenström's macroglobulinemia 2023 ·SHILAP Revista de lepidopterología ·(unknown), Kunihiko Haráda, Y. Uchino, (unknown), Naohiro Sekiguchi	1
3	Two‐year outcomes of tirabrutinib monotherapy in Waldenström’s macroglobulinemia 2022 ·Cancer Science ·Naohiro Sekiguchi, Shinya Rai, Wataru Munakata, Kenshi Suzuki, Hiroshi Handa, Hirohiko Shibayama, Tomoyuki Endo, Yasuhito Terui, Noriko Iwaki, Noriko Fukuhara, Hiro Tatetsu, Shinsuke Iida, Takayuki Ishikawa, (unknown), Koji Izutsu	22
4	Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study 2022 ·International Journal of Hematology ·Takaaki Ono, Masayuki Hino, Itaru Matsumura, Shin Fujisawa, Kenichi Ishizawa, Emiko Sakaida, Naohiro Sekiguchi, Chiho Ono, (unknown), (unknown), (unknown), Naoto Takahashi	7
5	Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia 2022 ·International Journal of Hematology ·Naohiro Sekiguchi, Senji Kasahara, Toshihiro Miyamoto, Toru Kiguchi, Hitoshi Ohno, (unknown), Masaya Tachibana, Hiroyuki Sumi, Yasuyuki Kakurai, (unknown), Kensuke Usuki	10
6	A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström’s macroglobulinemia 2020 ·Cancer Science ·Naohiro Sekiguchi, Shinya Rai, Wataru Munakata, Kenshi Suzuki, Hiroshi Handa, Hirohiko Shibayama, Tomoyuki Endo, Yasuhito Terui, Noriko Iwaki, Noriko Fukuhara, Hiro Tatetsu, Shinsuke Iida, Takayuki Ishikawa, (unknown), Koji Izutsu	60
7	What is the most appropriate regimen for untreated Waldenström macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness 2019 ·Blood Research ·Naohiro Sekiguchi, (unknown), Tomoko Kitagawa, Ken‐ichi Ito, (unknown), Kazuaki Yamada	1
8	Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent 2018 ·Blood Research ·Naohiro Sekiguchi, (unknown), Tomoko Kitagawa, (unknown), Ken‐ichi Ito, (unknown), Kozo Watanabe, (unknown), (unknown), Kazuaki Yamada, Naoki Takezako	4
9	Significance of lymphocyte counts at diagnosis in the management of ITP: the relationship between lymphocyte counts and treatment success in H. pylori-infected patients 2015 ·International Journal of Hematology ·Akihisa Nagata, Naohiro Sekiguchi, (unknown), (unknown), Naoki Takezako	4
10	Lymphocytosis in Idiopathic Thrombocytopenic Purpura Patients Infected by <i>Helicobacter pylori</i> 2013 ·Naoki Takezako, Naohiro Sekiguchi, Akira Tanimura, Chiho Homma, (unknown), (unknown), Noboru Yamagata, Akiyoshi Miwa	3
11	Deletion of the TNFAIP3/A20gene detected by FICTION analysis in classical Hodgkin lymphoma 2012 ·BMC Cancer ·Junko Nomoto, Nobuhiro Hiramoto, Motohiro Kato, Masashi Sanada, Akiko Miyagi Maeshima, Hirokazu Taniguchi, Fumie Hosoda, Yoshitaka Asakura, Wataru Munakata, Naohiro Sekiguchi, Dai Maruyama, Takashi Watanabe, Hitoshi Nakagama, Kengo Takeuchi, Kensei Tobinai, Seishi Ogawa, Yukio Kobayashi	31
12	Bortezomib, Dexamethasone, and High-Dose Melphalan as Conditioning for Stem Cell Transplantation in Young Japanese Multiple Myeloma Patients: A Pilot Study 2012 ·Indian Journal of Hematology and Blood Transfusion ·Naoki Takezako, Naohiro Sekiguchi, Akihisa Nagata, Chiho Homma, (unknown), Akiyoshi Miwa	2
13	[Significance of bortezomib and dexamethasone therapy for multiple myeloma showing a serum creatinine level above 2 mg/dl]. 2011 ·PubMed ·Naohiro Sekiguchi, Naoki Takezako, (unknown), Akihisa Nagata, (unknown), Akiyoshi Miwa	1
14	Ranimustine, ifosfamide, procarbazine, dexamethasone, and etoposide therapy for central nervous system recurrence of diffuse large B-cell lymphoma in patients with poor performance status: a pilot study 2011 ·Leukemia & lymphoma ·Akiyoshi Miwa, Naohiro Sekiguchi, (unknown), Chiho Homma, (unknown), (unknown), Noboru Yamagata, Naoki Takezako	0
15	Primary Ocular Adnexal MALT Lymphoma: A Long-term Follow-up Study of 114 Patients 2007 ·Japanese Journal of Clinical Oncology ·Kazuki Tanimoto, Akihiro Kaneko, Shigenobu Suzuki, Naohiro Sekiguchi, Takashi Watanabe, Yukio Kobayashi, Yoshikazu Kagami, Akiko Miyagi Maeshima, Yoshihiro Matsuno, Kensei Tobinai	42
16	Fluorescence in situhybridization (FISH) analysis of primary ocular adnexal MALT lymphoma 2006 ·BMC Cancer ·Kazuki Tanimoto, Naohiro Sekiguchi, (unknown), Akihiro Kaneko, Takashi Watanabe, Akiko Miyagi Maeshima, Yoshihiro Matsuno, Mine Harada, Kensei Tobinai, Yukio Kobayashi	42
17	Follicular lymphoma subgrouping by fluorescence in situ hybridization analysis 2005 ·Cancer Science ·Naohiro Sekiguchi, Yukio Kobayashi, (unknown), Shigeru Kusumoto, Kazuki Tanimoto, Takashi Watanabe, Yoshihiro Matsuno, Kensei Tobinai	32
18	Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma 2005 ·Annals of Oncology ·Kazuki Tanimoto, Akihiro Kaneko, Shigenobu Suzuki, Naohiro Sekiguchi, Dai Maruyama, (unknown), Takashi Watanabe, Yukio Kobayashi, Yoshikazu Kagami, (unknown), Yoshihiro Matsuno, Kensei Tobinai	79
19	Early cytomegalovirus (CMV) gastrointestinal disease that developed 19 days after bone marrow transplantation, with a high-level of CMV antigenemia, of up to 1120 cells/slide 2004 ·Journal of Infection and Chemotherapy ·Shingo Yano, Noriko Usui, Osamu Asai, Nobuaki Dobashi, (unknown), Takeshi Saito, Naohiro Sekiguchi, Akihiro Shimizu, Satsuki Iwase, Masayuki Kobayashi	1
20	Intensified Daunorubicin in Induction Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Postremission Therapy (Double-7 Protocol) for Adult Acute Myeloid Leukemia 2002 ·International Journal of Hematology ·Noriko Usui, Nobuaki Dobashi, Osamu Asai, Shingo Yano, Yuichi Yahagi, Takeshi Saito, Yuko Yamaguchi, (unknown), Yutaka Okawa, Naohiro Sekiguchi, Yutaka Takei, (unknown), Yoji Ogasawara, (unknown), Ken Kaito, Masayuki Kobayashi	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact